Debasish F Roychowdhury

Summary

Affiliation: Eli Lilly and Company
Country: USA

Publications

  1. ncbi request reprint A report on serious pulmonary toxicity associated with gemcitabine-based therapy
    Debasish F Roychowdhury
    Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA
    Invest New Drugs 20:311-5. 2002
  2. ncbi request reprint Health-related quality-of-life parameters as independent prognostic factors in advanced or metastatic bladder cancer
    D F Roychowdhury
    Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA
    J Clin Oncol 21:673-8. 2003
  3. ncbi request reprint The value of label recommendations: how to dose lapatinib
    Kevin M Koch
    J Clin Oncol 25:5331-2; author reply 5334-5. 2007

Collaborators

Detail Information

Publications3

  1. ncbi request reprint A report on serious pulmonary toxicity associated with gemcitabine-based therapy
    Debasish F Roychowdhury
    Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA
    Invest New Drugs 20:311-5. 2002
    ..However, the incidence of SPT has not been fully evaluated. This retrospective review estimates the incidence of, and the factors influencing, SPT with G...
  2. ncbi request reprint Health-related quality-of-life parameters as independent prognostic factors in advanced or metastatic bladder cancer
    D F Roychowdhury
    Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA
    J Clin Oncol 21:673-8. 2003
    ....
  3. ncbi request reprint The value of label recommendations: how to dose lapatinib
    Kevin M Koch
    J Clin Oncol 25:5331-2; author reply 5334-5. 2007